Transpulmonary chemoembolization and microwave ablation for recurrent or advanced non-small cell Lung Cancer.

Sci Rep · 2024 · PMC11513032 · PMID 39462003

Europe PMC DOI

hedged sentences

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

borderline significantp = 0.06so close (0.05 < p ≤ 0.1)

13%, p = 0.00) than those remaining in ITS > 3 cm; however, only borderline significant better MST was demonstrated in this subgroup than those remaining in ITS > 3 cm (22.2 vs. 15.8 months, p = 0.06).

also in 11,409 other papers

borderline significanceno p-value reported

21% of the included patients in ITS > 3 cm shifted to ITS ≤ 3 cm and showed survival benefits compared to those who remained in ITS > 3 cm with borderline significance.

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.